Related Experiment Videos
Cytogenetic and molecular changes in chronic B-cell leukemia
1Cytogenetic and Molecular Oncology Unit, Christchurch Hospital, New Zealand.
Cancer Genetics and Cytogenetics
|December 1, 1989
Summary
Approximately 50% of chronic B-cell leukemia (CLL) patients exhibit chromosome abnormalities, most commonly an extra chromosome 12. Oncogene activation appears uncommon in CLL pathogenesis, warranting further genetic investigation.
Area of Science:
- Cytogenetics
- Molecular Biology
- Hematology
Background:
- Chronic B-cell leukemia (CLL) is characterized by specific genetic alterations.
- Cytogenetic abnormalities are found in about half of CLL patients.
Purpose of the Study:
- To investigate the spectrum of chromosome abnormalities in CLL.
- To identify genes involved in CLL pathogenesis.
Main Methods:
- Cytogenetic analysis using B-cell mitogens.
- Detection of chromosome translocations and gene identification.
Main Results:
- 50% of CLL patients showed chromosome abnormalities.
- The most frequent abnormality was trisomy 12.
- Translocations t(11;14) and t(14;19) identified bcl-1 and bcl-3 genes.
Conclusions:
- Chromosome abnormalities are common in CLL, with trisomy 12 being prevalent.
- Specific translocations have led to the discovery of oncogenes.
- Oncogene activation is not a primary driver in CLL pathogenesis.